These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3053944)

  • 1. [The beneficial effect of human urinary colony-stimulating factor (P-100) on recovery from granulocytopenia after anti-cancer chemotherapy for gynecologic cancer].
    Kasamatsu T; Tsunematsu R; Ueda K; Miyagawa N; Kawana T; Kawagoe K; Takizawa K; Takaku F; Mizuno M; Yoshikawa H
    Nihon Gan Chiryo Gakkai Shi; 1988 Jul; 23(7):1551-9. PubMed ID: 3053944
    [No Abstract]   [Full Text] [Related]  

  • 2. [Granulocytopoietic effect of human urinary colony-stimulating factor on prolonged granulocytopenia after cancer chemotherapy (clinical phase III study)].
    Motoyoshi K; Takaku F; Masaoka T; Miyazaki T; Shibata A; Omine M; Kimura K; Miura Y; Furusawa S; Abe T
    Nihon Gan Chiryo Gakkai Shi; 1988 Dec; 23(11):2760-8. PubMed ID: 3074145
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical trial of CSF-HU (colony-stimulating factor derived from human urine: P-100) on granulocytopenia induced by anticancer therapy in urogenital cancer patients].
    Matsumoto K; Kakizoe T; Nakagami Y; Rin S; Ito H; Koyanagi T; Sakashita S; Nagayama T; Miyauchi T; Toyoshima A
    Hinyokika Kiyo; 1987 Jun; 33(6):972-82. PubMed ID: 3499770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical study on the effect of CSF-HU (colony stimulating factor human urine) on leukopenia and granulocytopenia induced by cancer chemotherapy--a double-blind study in patients with genito-urinary cancer].
    Niijima T; Aso Y; Akaza H; Kawai T; Matsumoto K; Tachibana M; Nishio Y; Kotake T; Takaku F; Matsumura Y
    Hinyokika Kiyo; 1988 Aug; 34(8):1483-92. PubMed ID: 3057832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of partially purified human urinary colony-stimulating factor on granulocytopenia after antitumor chemotherapy.
    Motoyoshi K; Takaku F; Maekawa T; Miura Y; Kimura K; Furusawa S; Hattori M; Nomura T; Mizoguchi H; Ogawa M
    Exp Hematol; 1986 Dec; 14(11):1069-75. PubMed ID: 3490992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A phase II clinical trial of human urinary CSF (P-100) in pediatric patients].
    Tsuchida M; Ohara A; Tsukimoto I; Hanawa Y; Akatsuka J; Hoshi Y; Ueda Y; Yamamoto M; Akabane T; Komiyama J
    Rinsho Ketsueki; 1988 Jul; 29(7):1041-9. PubMed ID: 2460650
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of recombinant human granulocyte colony stimulating factor on granulocytopenia induced by cytotoxic chemotherapy in patients with multiple myeloma.
    Pogłód R; Kraj M; Maj S
    Mater Med Pol; 1995; 27(3):83-9. PubMed ID: 8935143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical effect of recombinant human G-CSF on neutropenia induced by chemotherapy for lung cancer. rG.CSF Cooperation Study Group].
    Ota K; Ariyoshi Y; Fukuoka M; Furuse K; Niitani H
    Gan To Kagaku Ryoho; 1990 Jan; 17(1):65-71. PubMed ID: 1688700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of recombinant human granulocyte colony-stimulating factor (rG-CSF) on chemotherapy-induced neutropenia in patients with lung cancer].
    Ohnoshi T; Ueoka H; Kodani T; Kamei H; Kimura I
    Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 2):911-8. PubMed ID: 1693062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expectations in the clinical application of human-recombinant cytokines. 4) Interleukin-3 and colony-stimulation factors].
    Takaku F
    Nihon Rinsho; 1988 May; 46(5):1105-11. PubMed ID: 2457722
    [No Abstract]   [Full Text] [Related]  

  • 11. [GM-CSF: its use in onco-hematologic diseases].
    Visani G; Tosi P; Benfenati D; Colombini R; Cenacchi AR; Gamberi B; Lemoli RM; Tura S
    Haematologica; 1989 Oct; 74(5 Suppl):501-10. PubMed ID: 2512232
    [No Abstract]   [Full Text] [Related]  

  • 12. [Colony-stimulating factors in cancer chemo- and radiotherapy].
    Okabe T
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):810-9. PubMed ID: 2455481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of recombinant human granulocyte colony stimulating factor (rhG-CSF) in patients receiving chemotherapy--phase I study].
    Fukutani H; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Nagamine D; Shinagawa K; Tabata M; Hirano A; Mizunuma N
    Gan To Kagaku Ryoho; 1989 May; 16(5):2005-12. PubMed ID: 2471461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hematopoietic growth factors as supportive treatment in drug-induced agranulocytosis].
    Hospers GA; de Wolf JT; Hazenberg BP; Vellenga E
    Ned Tijdschr Geneeskd; 1993 Oct; 137(42):2152-4. PubMed ID: 7694163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effect of dolichyl phosphate and human recombinant granulocyte colony-stimulating factor on recovery from neutropenia in mice treated with anti-cancer drugs.
    Shimamura M; Takigawa T; Urabe A; Okabe T; Souza LM; Takaku F
    Exp Hematol; 1988 Sep; 16(8):681-5. PubMed ID: 2456942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug-induced agranulocytosis: response to treatment].
    Campodarve I; Mínguez S; Knobel H; Supervía A
    Med Clin (Barc); 1993 May; 100(18):717. PubMed ID: 8492603
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of recombinant human granulocyte-macrophage colony-stimulating factor as treatment for aplastic anemia and agranulocytosis.
    Champlin RE; Nimer SD; Oette D; Golde DW
    Prog Clin Biol Res; 1990; 338():143-50. PubMed ID: 2189137
    [No Abstract]   [Full Text] [Related]  

  • 18. Human recombinant hemopoietic growth factors G-CSF and GM-CSF: first results of clinical trials.
    Nissen-Druey C
    Nouv Rev Fr Hematol (1978); 1989; 31(2):99-101. PubMed ID: 2475852
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression.
    Antman KS; Griffin JD; Elias A; Socinski MA; Ryan L; Cannistra SA; Oette D; Whitley M; Frei E; Schnipper LE
    N Engl J Med; 1988 Sep; 319(10):593-8. PubMed ID: 3045544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of colony-stimulating factors as possible therapeutic agents].
    Testa U
    Ann Ist Super Sanita; 1989; 25(2):363-7. PubMed ID: 2511793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.